Safety and Efficacy Study of Peripheral Blood Mononucleated Cells for Treatment of Liver Cirrhosis

Phase 1 Completed 9 enrolled Seoul National University Hospital

RandomizedFactorialOpen-labelTreatment

Summary

The investigators aim to investigate the safety and efficacy of peripheral blood monocyte for the treatment of patients with advanced liver cirrhosis.

Timeline

Start: 2012-01
Primary completion: 2013-07
Completion: 2014-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	G-Colony-Stimulating Factor	Unknown	5 ug/kg	Subcutaneous

Safety and Efficacy Study of Peripheral Blood Mononucleated Cells for Treatment of Liver Cirrhosis

Summary

Timeline

Drugs

Indications